The relationship of ischemia-modified albumin levels to disease activity scores and HLA-B27 in patients with ankylosing spondylitis

Sertpoyraz F. M., Çolak A., Dikici A., Erdinç Gündüz N., Zeytinli Akşit M.

NORTHERN CLINICS OF ISTANBUL = ISTANBUL KUZEY KLINIKLERI, cilt.8, sa.1, ss.42-48, 2020 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 8 Sayı: 1
  • Basım Tarihi: 2020
  • Doi Numarası: 10.14744/nci.2020.23590
  • Dergi Adı: NORTHERN CLINICS OF ISTANBUL = ISTANBUL KUZEY KLINIKLERI
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.42-48
  • Anahtar Kelimeler: Ankylosing spondylitis, disease activity, ischemia-modified albumin, OXIDATIVE STRESS, BONE TURNOVER, INFLAMMATION, BIOMARKER, MARKER
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

OBJECTIVE: Recent studies have implicated increased oxidative stress in the pathogenesis of Ankylosing spondylitis (AS). Ischemia-modified albumin (IMA), an altered form of albumin, increases oxidative stress. This study aimed to investigate the relationship between IMA levels and other indicators of disease severity in AS.